Skip to main content

Table 2 Logistic regression analysis for overall survival and ERCC1 polymorphisms

From: ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

A

    
 

Odds ratio

95% CI lower

95% CI upper

p-value

C8092A

1.957

1.276

5.675

0.036

T19007C

3.875

1.865

18.851

0.004

B

    
 

Odds ratio

95% CI lower

95% CI upper

p-value

C8092 + T19007

2.479

0.538

11.421

0.244

8092A + 19007C

5.609

1.278

24.622

0.022